Age distribution of cases caused by different influenza viruses

The Lancet Infectious Diseases

Volumn 13, Issue 8, 2013, Pages 646-647

  Rimmelzwaan, Guus F ^a   Fouchier, Ron AM ^a   Osterhaus, Albert DME ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGING; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INNATE IMMUNITY; LETTER; PANDEMIC; PANDEMIC INFLUENZA; PNEUMONIA; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL RESPIRATORY TRACT INFECTION;

AGE DISTRIBUTION; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN;

EID: 84880654202     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70181-6     Document Type: Letter

References (17)

1. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013, 368:1888-1897.
2. Number of confirmed human cases of avian influenza A(H7N9) reported to WHO WHO, (accessed July 3, 2013). http://www.who.int/influenza/human_animal_interface/influenza_h7n9/08_ReportWebH7N9Number.pdf.
3. MCEIRS, (accessed July 5, 2013). http://www.cidrap.umn.edu/sites/default/files/public/downloads/topics/mceirs_h7n9_graphs.pdf.
4. Arima Y, Zu R, Murhekar M, Vong S, Shimada T Human infections with avian influenza A(H7N9) virus in China: preliminary assessments of the age and sex distribution. WPSAR 2013, 4:1-3.
5. Li Q, Zhou L, Zhou M, et al. Preliminary report: epidemiology of the avian influenza A(H7N9) outbreak in China. N Engl J Med 2013, published online April 24. 10.1056/NEJMoa1304617.
6. Meyer KC The role of immunity in susceptibility to respiratory infection in the aging lung. Respir Physiol 2001, 128:23-31.
7. Smits SL, de Lang A, van den Brand JM, et al. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog 2010, 6:e1000756.
8. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
9. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
10. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025.
11. Skountzou I, Koutsonanos DG, Kim JH, et al. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 2010, 185:1642-1649.
12. Hillaire ML, van Trierum SE, Bodewes R, et al. Characterization of the human CD8(+) T cell response following infection with 2009 pandemic influenza H1N1 virus. J Virol 2011, 85:12057-12061.
13. Bodewes R, Fraaij PL, Geelhoed-Mieras MM, et al. Annual vaccination against influenza virus hampers development of virus-specific CD8(+) T cell immunity in children. J Virol 2011, 85:11995-12000.
14. Bodewes R, Fraaij PL, Kreijtz JH, et al. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 2012, 30:7407-7410.
15. Huisman W, Martina BE, Rimmelzwaan GF, Gruters RA, Osterhaus AD Vaccine-induced enhancement of viral infections. Vaccine 2009, 27:505-512.
16. Epstein SL Prior H1N1 influenza infection and susceptibility of Cleveland family study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006, 193:49-53.
17. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 2007, 4:e59.